Home » Elan Clarifies Reported News on Bapineuzumab Phase 3 Trials Duration
Elan Clarifies Reported News on Bapineuzumab Phase 3 Trials Duration
Elan Corp. clarified the recent reports that stated that the duration of the bapineuzumab Phase 3 clinical trials may be extended.
RTTNews
RTTNews
Upcoming Events
-
07May
-
14May
-
23May
-
30May
-
20Jun
-
21Oct